Literature DB >> 16980632

Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.

Li Jia1, Howard C Shen, Marcus Wantroba, Omar Khalid, Gangning Liang, Qingcai Wang, Elisabet Gentzschein, Jacek K Pinski, Frank Z Stanczyk, Peter A Jones, Gerhard A Coetzee.   

Abstract

Prostate cancers (PCas) become resistant to hormone withdrawal through increased androgen receptor (AR) signaling. Here we show increased AR-mediated transcription efficiency in PCa cells that have acquired the ability to grow in low concentrations of androgen. Compared to androgen-dependent PCa cells, these cells showed increased activity of transiently transfected reporters and increased mRNA synthesis relative to levels of AR occupancy of the prostate-specific antigen (PSA) gene. The locus also displayed up to 10-fold-higher levels of histone H3-K9/K14 acetylation and H3-K4 methylation across the entire body of the gene. Although similar increased mRNA expression and locus-wide histone acetylation were also observed at another kallikrein locus (KLK2), at a third AR target locus (TMPRSS2) increased gene expression and locus-wide histone acetylation were not seen in the absence of ligand. Androgen-independent PCa cells have thus evolved three distinctive alterations in AR-mediated transcription. First, increased RNA polymerase initiation and processivity contributed to increased gene expression. Second, AR signaling was more sensitive to ligand. Third, locus-wide chromatin remodeling conducive to the increased gene expression in the absence of ligand was apparent and depended on sustained AR activity. Therefore, increased AR ligand sensitivity as well as locus-specific chromatin alterations contribute to basal gene expression of a subpopulation of specific AR target genes in androgen-independent PCa cells. These features contribute to the androgen-independent phenotype of these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980632      PMCID: PMC1592894          DOI: 10.1128/MCB.00581-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

Authors:  Tatsuya Nakamura; Toshiki Mori; Shinichiro Tada; Wladyslaw Krajewski; Tanya Rozovskaia; Richard Wassell; Garrett Dubois; Alexander Mazo; Carlo M Croce; Eli Canaani
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

2.  Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft.

Authors:  Desok Kim; Christopher W Gregory; Frank S French; Gary J Smith; James L Mohler
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

Authors:  Zhigang Kang; Asta Pirskanen; Olli A Jänne; Jorma J Palvimo
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

Review 4.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.

Authors:  Bonnie J Deroo; Claudia Rentsch; Sowmini Sampath; Janel Young; Donald B DeFranco; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 6.  Androgen receptor as a target in androgen-independent prostate cancer.

Authors:  Steven P Balk
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

7.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

Review 8.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.

Authors:  Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

9.  Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Authors:  Samuel R Denmeade; Lori J Sokoll; Susan Dalrymple; D Marc Rosen; Alyssa M Gady; Debra Bruzek; Rebecca M Ricklis; John T Isaacs
Journal:  Prostate       Date:  2003-03-01       Impact factor: 4.104

Review 10.  Contribution of the androgen receptor to prostate cancer predisposition and progression.

Authors:  G Buchanan; R A Irvine; G A Coetzee; W D Tilley
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

View more
  29 in total

Review 1.  Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

Authors:  Huanjie Yang; Q Ping Dou
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

2.  The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.

Authors:  Sathish Kasina; Jill A Macoska
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

Review 3.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

4.  Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.

Authors:  Derek S Welsbie; Jin Xu; Yu Chen; Laetitia Borsu; Howard I Scher; Neal Rosen; Charles L Sawyers
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  Genome-wide DNA methylation profiling of CpG islands in hypospadias.

Authors:  Shweta Choudhry; Archana Deshpande; Liang Qiao; Kenneth Beckman; Saunak Sen; Laurence S Baskin
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

6.  Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.

Authors:  Unnati Jariwala; Jon P Cogan; Li Jia; Baruch Frenkel; Gerhard A Coetzee
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

7.  Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.

Authors:  Sanjeev K Baniwal; Omar Khalid; Donna Sir; Grant Buchanan; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Endocrinol       Date:  2009-04-23

Review 8.  What goes on behind closed doors: physiological versus pharmacological steroid hormone actions.

Authors:  S Stoney Simons
Journal:  Bioessays       Date:  2008-08       Impact factor: 4.345

9.  Functional enhancers at the gene-poor 8q24 cancer-linked locus.

Authors:  Li Jia; Gilad Landan; Mark Pomerantz; Rami Jaschek; Paula Herman; David Reich; Chunli Yan; Omar Khalid; Phil Kantoff; William Oh; J Robert Manak; Benjamin P Berman; Brian E Henderson; Baruch Frenkel; Christopher A Haiman; Matthew Freedman; Amos Tanay; Gerhard A Coetzee
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

10.  Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.

Authors:  Harri Makkonen; Miia Kauhanen; Ville Paakinaho; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Nucleic Acids Res       Date:  2009-05-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.